Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 9:07 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 121–144 of 1,407 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cardiovascular Function Clear all

Conditions: Stroke, Rehabilitation, Hand
Interventions: transcranial direct current stimulation and electrical stimulator; Device
Lead sponsor: MetroHealth Medical Center; Other
Eligibility: 21 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2028
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Coronary Artery Disease
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 21 Years and older
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Type 2 Diabetes
Interventions: Bydureon, placebo; Drug
Lead sponsor: Phoenix VA Health Care System; Federal
Eligibility: 21 Years to 75 Years
Enrollment: 148 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Cardiovascular Disease
Interventions: Vivo Heart; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 60 Years to 80 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Single-ventricle, Congenital Heart Disease
Interventions: Not listed
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 3 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Atrial Functional Mitral Regurgitation, Mitral Insufficiency
Interventions: Not listed
Lead sponsor: University Hospital of Cologne; Other
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2035
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: HIV Infections, Cardiovascular Disease, Insulin Resistance, HIV Lipodystrophy, The Metabolic Syndrome
Interventions: Pioglitazone, Exercise Training; Drug · Behavioral
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 28 Years to 50 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Stroke, Cerebrovascular Disorders, Brain Ischemia, Infarction
Interventions: Accelerated Skill Acquisition Program (ASAP), Active Monitoring; Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: 21 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Nonhemorrhagic Ischemic Stroke, Motor Function
Interventions: Observational study; Other
Lead sponsor: Daiichi Sankyo; Industry
Eligibility: 21 Years to 85 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 22
States / cities: Newport Beach, California • Englewood, Colorado • Lawrenceville, Georgia + 18 more

Conditions: Congestive Heart Failure
Interventions: Paradym CRT + Physiological Diagnosis (PhD); Device
Lead sponsor: ELA Medical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 520 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Mesa, Arizona

Conditions: Quality of Life, Aging, Memory Loss, Cardiovascular Diseases
Interventions: Resistance Exercise; Other
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 60 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Left Ventricular Dysfunction, Coronary Artery Disease
Interventions: Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®, IABP Intra-aortic balloon pump; Device
Lead sponsor: Abiomed Inc.; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 1,252 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 83
States / cities: Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 65 more

Conditions: Right Hemispheric Stroke
Interventions: Aprosodia Intervention, No-Intervention; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 89 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Stroke, Osteopathic Medicine, Physical Examination, Heart Rate Variability (HRV), Energy Expenditure, Patient Reported Outcome (PRO)
Interventions: Not listed
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Acute Coronary Syndrome
Interventions: EndoPAT testing (non invasive device), WatchPAT testing (non-invasive device); Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Kidney Transplant; Complications, Vascular Diseases, Diabetes
Interventions: Dapagliflozin 10mg Tab, Placebo; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 80 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Fabry Disease
Interventions: Replagal; Biological
Lead sponsor: Shire; Industry
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 4
States / cities: Tucson, Arizona • Iowa City, Iowa • New York, New York + 1 more

Conditions: Reperfusion Injury, Liver Injury
Interventions: inhaled nitric oxide, nitrogen gas; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years to 80 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 2
States / cities: Birmingham, Alabama • Seattle, Washington

Conditions: Hypertension
Interventions: Nebivolol; Drug
Lead sponsor: Mercy Research; Other
Eligibility: 18 Years to 90 Years
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Ischemic Optic Neuropathy, Branch Retinal Artery Occlusion, Hemianopia, Leber Hereditary Optic Neuropathy, Acute Zonal Occult Outer Retinopathy
Interventions: LSFG-NAVI; Device
Lead sponsor: Randy Kardon; Other
Eligibility: 18 Years to 99 Years
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2028
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Stroke, Stroke, Acute, Stroke, Ischemic
Interventions: Frequent PT, Intense PT; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 80 Years
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Atherosclerosis, Heart Failure, Congestive, Hypertension, Myocardial Infarction
Interventions: Angiotensin II type 1 receptor antagonists; Drug
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: Not listed
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2000
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Stroke, Hemiparesis
Interventions: Shoulder Abduction; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Coronary Artery Disease, Coronary Stenosis
Interventions: ICA (Invasive Coronary Angiography), OCT, FFR, VFR Analysis; Procedure · Other
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 312 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 28
States / cities: Huntsville, Alabama • Scottsdale, Arizona • Little Rock, Arkansas + 22 more

Search by objective public record fields.

Improving Stroke Motor Control With Non-invasive Brain Stimulation and Functional Electrical Stimulation

Biomarkers for Cardiovascular Disease

Effect of Bydureon on Carotid Atherosclerosis Progression in Type 2 Diabetes Mellitus

Vivo Heart: Home-Based Virtual Exercise Program for Older Adults With Cardiovascular Disease

Fontan Imaging Biomarkers (FIB) Study

Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIAL-MR)

Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome

Dose Optimization for Stroke Evaluation

Observational Study to Evaluate the Simplified-STroke REhabilitation Assessment of Movement (S-STREAM) Scale in Subjects Who Have Experienced a Nonhemorrhagic Ischemic Stroke

Evaluation of a Diagnostic Feature in a Cardiac Resynchronization Therapy (CRT) Device

Functional Outcomes of Stay Strong Stay Healthy Program

Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function

Functional Connectivity and Predictors of Affective Aprosodia Intervention in Subacute Right Hemisphere Stroke

Examining Relationships Between Musculoskeletal Function Measurements of Movement Efficiency and Nervous System Function After Chronic Stroke

Prediction of Cardiovascular Events in Vulnerable Patients Following Acute Coronary Syndrome

Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients

Safety and Efficacy Study of Several Replagal Dosing Regimens on Cardiac Function in Adults With Fabry Disease

Study to Evaluate if Inhaled Nitric Oxide Improves Liver Function After Transplantation

Effects of Nebivolol on Exercise Tolerance and Left Ventricular Systolic and Diastolic Function

New Non-invasive Modalities for Assessing Retinal Structure and Function

Frequency vs Error Augmentation Training in Acute Physical Therapy Post Stroke

The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular Function

Mapping Corticoreticulospinal Motor Control in Chronic Hemiparetic Stroke

FUnctional diagnoSIs of corONary Stenosis (FUSION)